Who Develops Innovations in Medicine for the Poor? Trends in Patent Applications Related to Medicines for HIV/AIDS, Tuberculosis, Malaria and Neglected Diseases
利用統計を見る
Who invents medicines for the poor of the world? This question becomes very important where the WTO allows low income countries to be unbound by the TRIPS agreement.
This agreement concerns medicines for infectious diseases such as HIV/AIDS, tuberculosis and malaria. These diseases cause serious damage to low income countries. Under these circumstances, some scholars wonder if anyone will continue innovative activities related to treating these diseases.
This paper sought to answer this question by collecting and analyzing patent data of medicines and vaccines for diseases using the database of the Japan Patent Office. Results indicate that private firms have led in innovation not only for global diseases such as HIV/AIDS but also diseases such as malaria that are spreading exclusively in low income countries.
Innovation for the three infectious diseases is diverse among firms, and frequent patent applications by high-performing pharmaceutical firms appear prominent even after R&D expenditure, economies of scale, and economies of scope are taken into account.
権利
Copyrights 日本貿易振興機構(ジェトロ)アジア経済研究所 / Institute of Developing Economies, Japan External Trade Organization (IDE-JETRO) http://www.ide.go.jp
雑誌名
IDE Discussion Paper
雑誌名(英)
IDE Discussion Paper
巻
24
発行年
2005-04-01
出版者
Institute of Developing Economies (IDE-JETRO)
著者版フラグ
publisher
日本十進分類法
491.61
JEL分類
JEL:I19 - Other
JEL:L65 - Chemicals; Rubber; Drugs; Biotechnology
JEL:O31 - Innovation and Invention: Processes and Incentives
JEL:O34 - Intellectual Property Rights
地域/国名
発展途上国
キーワード(LSH)
HIV/AIDS
Malaria
Tuberculosis
Neglected diseases
Patents
Medicine
Knowledge production
Diseases
Medical care
Developing countries
エイズ
マラリア
結核
特許
疾病
医療
発展途上国